Patents Assigned to The University of Tennessee Research Corporation
  • Patent number: 4508795
    Abstract: A sodium-tetravalent sulfur molten chloroaluminate cell with a .beta."-alumina sodium ion conductor having a S-Al mole ratio of above about 0.15 in an acidic molten chloroaluminate cathode composition is disclosed. The cathode composition has an AlCl.sub.3 -NaCl mole percent ratio of above about 70-30 at theoretical full charge. The cell provides high energy densities at low temperatures and provides high energy densities and high power densities at moderate temperatures.
    Type: Grant
    Filed: February 10, 1984
    Date of Patent: April 2, 1985
    Assignee: University of Tennessee Research Corporation
    Inventor: Gleb Mamantov
  • Patent number: 4491588
    Abstract: A method is provided for treating psoriasis and seborrheic dermatitis in humans by oral administration of an effective, lesion reducing, amount of an imidazole antibiotic.
    Type: Grant
    Filed: March 17, 1983
    Date of Patent: January 1, 1985
    Assignee: University of Tennessee Research Corporation
    Inventors: E. William Rosenburg, Patricia W. Belew
  • Patent number: 4454121
    Abstract: Synthetic peptides corresponding to antigenic determinants of the M protein of streptococcus pyogenes are disclosed. These peptides are useful for vaccination against streptococcus pyogenes bacteria.
    Type: Grant
    Filed: July 27, 1982
    Date of Patent: June 12, 1984
    Assignee: The University of Tennessee Research Corporation
    Inventor: Edwin H. Beachey
  • Patent number: 4359415
    Abstract: The passage of human urine through a bed of adsorbent material results in the adsorption from the urine of antineoplastic substances as determined by in vitro tissue culture techniques utilizing human tumor cells. The adsorbent yields two antineoplastic fractions upon sequential elution. Elution of the low-molecular weight antineoplastic fraction is accomplished by elution with cold aqueous acetone at slightly alkaline pH. Thereafter, elution of the high molecular weight antineoplastic fraction is accomplished by elution with a cold aqueous acetone-glycerol mixture at slightly alkaline pH.The antineoplastic activities of these fractions are determined by tissue culture techniques employing a variety of human neoplastic cells. Furthermore, the high molecular weight fraction, the antineoplastic urinary protein, also inhibits the progression and causes regression of certain human tumor cells implanted in the nude mouse.
    Type: Grant
    Filed: June 3, 1981
    Date of Patent: November 16, 1982
    Assignee: University of Tennessee Research Corporation
    Inventor: Nathan H. Sloane